Novo Nordisk Reports - Industry Research

Carbonated Beverages Market Major Players

Clinical Trials Market

The Clinical Trials Market size is estimated at USD 50.66 billion in 2024, and is expected to reach USD 67.5 billion by 2029, growing at a CAGR of 5.91% during the forecast period (2024-2029).

Clinical Trials Support Services Market

The clinical trial support services market is expected to register a CAGR of 7.5% during the forecast period.

Anti-obesity Drugs Market

The anti-obesity drugs market is expected to register a CAGR of 15% over the forecast period.

Middle East And Africa Glucagon-like Peptide-1 (GLP-1) Agonists Market

The Middle East And Africa Glucagon-like Peptide-1 Agonists Market size is estimated at USD 124.32 million in 2024, and is expected to reach USD 175.28 million by 2029, growing at a CAGR of 7.26% during the forecast period (2024-2029).

Middle East And Africa Human Insulin Market

The Middle East And Africa Human Insulin Market size is estimated at USD 1.62 billion in 2024, and is expected to reach USD 1.95 billion by 2029, growing at a CAGR of 3.78% during the forecast period (2024-2029).

Middle East and Africa Diabetes Drugs Market

The Middle East and Africa Diabetes Drugs Market size is estimated at USD 4.57 billion in 2023 and is expected to reach USD 6.10 billion by 2028, growing at a CAGR of 5.97% during the forecast period (2023-2028).

North America Human Insulin Drugs Market

The North America Human Insulin Drugs Market size is estimated at USD 11.58 billion in 2024, and is expected to reach USD 14.03 billion by 2029, growing at a CAGR of 3.91% during the forecast period (2024-2029).

Human Insulin Drugs Market

The Human Insulin Drugs Market size is estimated at USD 27.96 billion in 2024, and is expected to reach USD 33.81 billion by 2029, growing at a CAGR of 3.87% during the forecast period (2024-2029).

Injectable Drugs Market

The Injectable Drugs Market size is estimated at USD 569.89 billion in 2024, and is expected to reach USD 820.05 billion by 2029, growing at a CAGR of 7.55% during the forecast period (2024-2029).

Meglitinide Market

The Meglitinide Market size is estimated at USD 4.35 billion in 2024, and is expected to reach USD 4.85 billion by 2029, growing at a CAGR of 2.21% during the forecast period (2024-2029).

Europe Insulin Delivery Devices Market

The Europe Insulin Delivery Devices Market size is estimated at USD 2.83 billion in 2024, and is expected to reach USD 3.12 billion by 2029, growing at a CAGR of 1.9% during the forecast period (2024-2029).

Insulin Pens Market

The Insulin Pens Market size is estimated at USD 33.31 billion in 2024, and is expected to reach USD 39.36 billion by 2029, growing at a CAGR of 3.40% during the forecast period (2024-2029).

Human Insulin Drugs And Delivery Devices Market

The Human Insulin Drugs And Delivery Devices Market size is estimated at USD 67.45 billion in 2024, and is expected to reach USD 80.99 billion by 2029, growing at a CAGR of 3.73% during the forecast period (2024-2029).

Russia Diabetes Care Devices Market

The Russia Diabetes Care Devices Market size is estimated at USD 1.34 billion in 2024, and is expected to reach USD 1.82 billion by 2029, growing at a CAGR of 4.53% during the forecast period (2024-2029).

Oman Diabetes Care Devices Market

The Oman Diabetes Care Devices Market size is estimated at USD 65.77 million in 2024, and is expected to reach USD 75.02 million by 2029, growing at a CAGR of 2.77% during the forecast period (2024-2029).

Mexico Diabetes Care Devices Market

The Mexico Diabetes Care Devices Market size is estimated at USD 503 million in 2024, and is expected to reach USD 697 million by 2029, growing at a CAGR of 5.98% during the forecast period (2024-2029).

Indonesia Diabetes Care Devices Market

The Indonesia Diabetes Care Devices Market size is estimated at USD 140.04 million in 2024, and is expected to reach USD 185.03 million by 2029, growing at a CAGR of 5.73% during the forecast period (2024-2029).

Iran Diabetes Care Devices Market

The Iran Diabetes Care Devices Market size is estimated at USD 752.91 million in 2024, and is expected to reach USD 938.26 million by 2029, growing at a CAGR of 4.5% during the forecast period (2024-2029).

Vietnam Diabetes Care Devices Market

The Vietnam Diabetes Care Devices Market size is estimated at USD 424.10 million in 2024, and is expected to reach USD 470.55 million by 2029, growing at a CAGR of 2.10% during the forecast period (2024-2029).

US Diabetes Care Drugs Market

The US Diabetes Care Drugs Market size is estimated at USD 32.59 billion in 2024, and is expected to reach USD 39.08 billion by 2029, growing at a CAGR of 3.70% during the forecast period (2024-2029).

Thailand Diabetes Care Drugs Market

The Thailand Diabetes Care Drugs Market size is estimated at USD 152.23 million in 2024, and is expected to reach USD 173.23 million by 2029, growing at a CAGR of 3.80% during the forecast period (2024-2029).

Philippines Diabetes Care Drugs Market

The Philippines Diabetes Care Drugs Market size is estimated at USD 264.24 million in 2024, and is expected to reach USD 319.95 million by 2029, growing at a CAGR of 3.9% during the forecast period (2024-2029).

South Korea Diabetes Drugs Market

The South Korea Diabetes Drugs Market size is estimated at USD 1 billion in 2024, and is expected to reach USD 1.22 billion by 2029, growing at a CAGR of 4.04% during the forecast period (2024-2029).

Iran Diabetes Care Drugs Market

The Iran Diabetes Care Drugs Market size is estimated at USD 331.92 million in 2024, and is expected to reach USD 401.90 million by 2029, growing at a CAGR of 3.9% during the forecast period (2024-2029).

Japan Diabetes Drugs Market

The Japan Diabetes Drugs Market size is estimated at USD 3.15 billion in 2024, and is expected to reach USD 4.03 billion by 2029, growing at a CAGR of 4.98% during the forecast period (2024-2029).

Asia-Pacific Insulin Pens Market

The Asia-Pacific Insulin Pens Market size is estimated at USD 17.46 billion in 2024, and is expected to reach USD 20.03 billion by 2029, growing at a CAGR of 2.70% during the forecast period (2024-2029).

United States Insulin Drugs And Delivery Devices Market

The United States Insulin Drugs And Delivery Devices Market size is estimated at USD 19.70 billion in 2024, and is expected to reach USD 22.5 billion by 2029, growing at a CAGR of 2.70% during the forecast period (2024-2029).

France Insulin Drugs And Delivery Devices Market

The France Insulin Drugs And Delivery Devices Market size is estimated at USD 736.48 million in 2024, and is expected to reach USD 789.49 million by 2029, growing at a CAGR of 1.40% during the forecast period (2024-2029).

UK Insulin Drugs And Delivery Devices Market

The UK Insulin Drugs And Delivery Devices Market size is estimated at USD 499.83 million in 2024, and is expected to reach USD 549.15 million by 2029, growing at a CAGR of 1.9% during the forecast period (2024-2029).

Canada Insulin Drugs And Delivery Devices Market

The Canada Insulin Drugs And Delivery Devices Market size is estimated at USD 1.68 billion in 2024, and is expected to reach USD 1.83 billion by 2029, growing at a CAGR of 1.7% during the forecast period (2024-2029).

Japan Insulin Drugs And Delivery Devices Market

The Japan Insulin Drugs And Delivery Devices Market size is estimated at USD 8.5 billion in 2024, and is expected to reach USD 9.57 billion by 2029, growing at a CAGR of 2.40% during the forecast period (2024-2029).

Australia Insulin Delivery Devices Market

The Australia Insulin Delivery Devices Market size is estimated at USD 705.52 million in 2024, and is expected to reach USD 794.35 million by 2029, growing at a CAGR of 2.40% during the forecast period (2024-2029).

India Insulin Drug And Delivery Device Market

India's Insulin Drug and Delivery Device Market is expected to register a CAGR of more than 1% and reach a value of about USD 2.4 billion over the forecast period.

Vietnam Insulin Drug And Delivery Device Market

Vietnam's Insulin Drug and Delivery Device Market is expected to register a CAGR of more than 2% and reach a value of about USD 483 million over the forecast period.

China Insulin Drugs And Delivery Devices Market

The China Insulin Drugs and Delivery Devices Market is expected to register a CAGR of 2.6% and reach a value of about USD 8.7 billion over the forecast period.

South Korea Insulin Drugs And Delivery Devices Market

The South Korea Insulin Drugs And Delivery Devices Market size is estimated at USD 756.38 million in 2024, and is expected to reach USD 849.04 million by 2029, growing at a CAGR of 2.34% during the forecast period (2024-2029).

Latin America Insulin Pens Market

The Latin America Insulin Pens Market size is estimated at USD 0.4 billion in 2024, and is expected to reach USD 0.52 billion by 2029, growing at a CAGR of greater than 1.8% during the forecast period (2024-2029).

US Diabetes Drugs And Devices Market

The US Diabetes Drugs And Devices Market size is estimated at USD 60.12 billion in 2024, and is expected to reach USD 70.24 billion by 2029, growing at a CAGR of greater than 4% during the forecast period (2024-2029).

South Africa Diabetes Drugs and Devices Market

South Africa's diabetes care drugs and devices market size was estimated at USD 0.47 billion in the current year.

Russia Diabetes Drugs and Devices Market

Russian diabetes drugs and devices market is estimated at USD 2.2 billion in the current year.

India Diabetes Drugs and Devices Market

India's diabetes care drugs and devices market size is estimated at USD 3.8 billion in the current year.

Australia Diabetes Drugs and Devices Market

The Australian diabetes drugs and devices market size is estimated at USD 1.4 billion in the current year.

South Korea Diabetes Drugs and Devices Market

South Korea's diabetes drugs and devices market size is estimated at USD 1.4 billion in the current year.

Vietnam Diabetes Drugs and Devices Market

Vietnam's diabetes drugs and devices market size is estimated at USD 0.6 billion in the current year.

Spain Diabetes Drugs and Devices Market

Spain's diabetes drugs and devices market is estimated at USD 0.7 billion in the current year.

Germany Diabetes Drugs and Devices Market

Germany's diabetes drugs and devices market size is estimated at USD 6 billion in the current year.

Egypt Diabetes Drugs and Devices Market

Egypt's diabetes drugs and devices market size is estimated at USD 0.7 billion in the current year.

Mexico Diabetes Drugs and Devices Market

Mexico's diabetes drugs and devices market size is estimated at USD 2.4 billion in the current year.

China Diabetes Drugs And Devices Market

The China Diabetes Drugs And Devices Market size is estimated at USD 19.66 billion in 2024, and is expected to reach USD 22.77 billion by 2029, growing at a CAGR of greater than 3.5% during the forecast period (2024-2029).

Japan Diabetes Drugs And Devices Market

The Japan Diabetes Drugs And Devices Market size is estimated at USD 4.80 billion in 2024, and is expected to reach USD 6.40 billion by 2029, growing at a CAGR of greater than 3.20% during the forecast period (2024-2029).

Thailand Diabetes Drugs And Devices Market

The Thailand Diabetes Drugs And Devices Market size is estimated at USD 0.28 billion in 2024, and is expected to reach USD 0.35 billion by 2029, growing at a CAGR of greater than 5.02% during the forecast period (2024-2029).

Philippines Diabetes Drugs and Devices Market

Philippines diabetes drugs and devices market size is estimated at USD 0.3 billion in the current year.

Oman Diabetes Drugs And Devices Market

The Oman Diabetes Drugs And Devices Market size is estimated at USD 199.07 million in 2024, and is expected to reach USD 274.19 million by 2029, growing at a CAGR of greater than 5% during the forecast period (2024-2029).

Iran Diabetes Drugs and Devices Market

Iran's diabetes drugs and devices market size is estimated at USD 1 billion in the current year.

Wegovy Market

The Wegovy Market size is estimated at USD 1.82 billion in 2024, and is expected to reach USD 2.67 billion by 2029, growing at a CAGR of greater than 7% during the forecast period (2024-2029).

Weight Loss Diabetes Drug Market

The Weight Loss Diabetes Drug Market size is estimated at USD 33.76 billion in 2024, and is expected to reach USD 43.26 billion by 2029, growing at a CAGR of greater than 5.5% during the forecast period (2024-2029).

Ozempic Market

The Ozempic Market size is estimated at USD 10.99 billion in 2024, and is expected to reach USD 16.5 billion by 2029, growing at a CAGR of greater than 8% during the forecast period (2024-2029).

Semaglutide Market

The Semaglutide Market size is estimated at USD 21 billion in 2024, and is expected to reach USD 33 billion by 2029, growing at a CAGR of 9.20% during the forecast period (2024-2029).

Liraglutide Market

The Liraglutide Market size is estimated at USD 3.40 billion in 2024, and is expected to reach USD 4 billion by 2029, growing at a CAGR of 3.16% during the forecast period (2024-2029).

Type 2 Diabetes Drugs And Devices Market

The Type 2 Diabetes Drugs And Devices Market size is estimated at USD 39 billion in 2024, and is expected to reach USD 61 billion by 2029, growing at a CAGR of greater than 9.20% during the forecast period (2024-2029).

Injectable Anti-diabetic Drugs Market

The Injectable Anti-diabetic Drugs Market size is estimated at USD 38.79 billion in 2024, and is expected to reach USD 45.10 billion by 2029, growing at a CAGR of greater than 3% during the forecast period (2024-2029).

Artificial Intelligence In Medicine Market

The Artificial Intelligence In Medicine Market size is estimated at USD 11.66 billion in 2024, and is expected to reach USD 36.79 billion by 2029, growing at a CAGR of 25.83% during the forecast period (2024-2029).

Europe Clinical Trials Market

The European clinical trials market is expected to register a CAGR of 4.2% over the forecast period.

Europe Insulin Drugs Market

The Europe Insulin Drugs Market size is estimated at USD 5.95 billion in 2024, and is expected to reach USD 7.55 billion by 2029, growing at a CAGR of 4.89% during the forecast period (2024-2029).

Japan Diabetes Care Devices Market

The Japan Diabetes Care Devices Market size is estimated at USD 1.73 billion in 2024, and is expected to reach USD 2.44 billion by 2029, growing at a CAGR of 7.26% during the forecast period (2024-2029).

Diabetes Care Drugs Market

The Diabetes Care Drugs Market size is estimated at USD 87.53 billion in 2024, and is expected to reach USD 104.01 billion by 2029, growing at a CAGR of 3.51% during the forecast period (2024-2029).

Insulin Delivery Devices Market

The Insulin Delivery Devices Market size is estimated at USD 39.57 billion in 2024, and is expected to reach USD 47.17 billion by 2029, growing at a CAGR of 3.57% during the forecast period (2024-2029).

Diabetes Care Devices Market

The Global Diabetes Care Devices Market size is estimated at USD 59,522.29 million in 2023 and is expected to reach USD 76,329.64 million by 2028, registering a CAGR of 5.10% during the forecast period (2023-2028).

Global Human Growth Hormone (HGH) Market

The human growth hormone market registered a market size of USD 4,632.54 million in 2020, and it is expected to reach USD 7,567.74 million by 2026, registering a CAGR of 8.61% during the forecast period, 2021-2026.

Europe Diabetes Drugs Market

The Europe Diabetes Drugs Market size is estimated at USD 16.43 billion in 2024, and is expected to reach USD 20.23 billion by 2029, growing at a CAGR of 4.25% during the forecast period (2024-2029).

Basal Insulin Market

The Basal Insulin Market size is estimated at USD 273.68 million in 2024, and is expected to reach USD 344.33 million by 2029, growing at a CAGR of 4.70% during the forecast period (2024-2029).

Hemophilia Market

The hemophilia market is expected to register a CAGR of 5.7% during the forecast period.

Denmark Pharmaceutical Market

Denmark Pharmaceutical Market is poised to grow at a CAGR of 3.4% during the forecast period (2022-2027).

New Zealand Insulin Drugs and Devices Market

The New Zealand Insulin Drugs and Devices Market size is estimated at USD 523.18 million in 2024, and is expected to reach USD 552.60 million by 2029, growing at a CAGR of 1.10% during the forecast period (2024-2029).

New Zealand Diabetes Drugs Market

The New Zealand Diabetes Drugs Market size is estimated at USD 717.24 million in 2024, and is expected to reach USD 872.63 million by 2029, growing at a CAGR of 4% during the forecast period (2024-2029).

New Zealand Diabetes Devices Market

The New Zealand Diabetes Devices Market size is estimated at USD 435.36 million in 2024, and is expected to reach USD 512.09 million by 2029, growing at a CAGR of 3.30% during the forecast period (2024-2029).

Asia-Pacific Diabetes Care Devices Market

The Asia-Pacific Diabetes Care Devices Market size is estimated at USD 22.77 billion in 2024, and is expected to reach USD 26.91 billion by 2029, growing at a CAGR of 3.5% during the forecast period (2024-2029).

Canada Diabetes Care Devices Market

The Canada Diabetes Care Devices Market size is estimated at USD 1.93 billion in 2024, and is expected to reach USD 2.47 billion by 2029, growing at a CAGR of 4.98% during the forecast period (2024-2029).

South Africa Diabetes Care Devices Market

The South Africa Diabetes Care Devices Market size is estimated at USD 151.96 million in 2024, and is expected to reach USD 186.30 million by 2029, growing at a CAGR of greater than 4.08% during the forecast period (2024-2029).

North America Clinical Trials Market

The North America clinical trials market is expected to register a CAGR of 8.1% during the forecast period.

Australia Diabetes Care Devices Market

The Australia Diabetes Care Devices Market size is estimated at USD 704.12 million in 2024, and is expected to reach USD 795.09 million by 2029, growing at a CAGR of 2.46% during the forecast period (2024-2029).

North America Diabetes Care Devices Market

The North America Diabetes Care Devices Market size is estimated at USD 27.52 billion in 2024, and is expected to reach USD 37.19 billion by 2029, growing at a CAGR of 6.21% during the forecast period (2024-2029).

France Diabetes Devices Market

The France Diabetes Devices Market size is estimated at USD 1.30 billion in 2024, and is expected to reach USD 1.79 billion by 2029, growing at a CAGR of 6.58% during the forecast period (2024-2029).

North America Diabetes Drugs Market

The North America Diabetes Drugs Market size is estimated at USD 35.82 billion in 2024, and is expected to reach USD 42.36 billion by 2029, growing at a CAGR of 3.58% during the forecast period (2024-2029).

Spain Diabetes Devices Market

The Spain Diabetes Devices Market size is estimated at USD 0.71 billion in 2024, and is expected to reach USD 1.02 billion by 2029, growing at a CAGR of 7.41% during the forecast period (2024-2029).

Europe Diabetes Care Devices Market

The Europe Diabetes Care Devices Market size is estimated at USD 8.03 billion in 2024, and is expected to reach USD 10.84 billion by 2029, growing at a CAGR of 6.18% during the forecast period (2024-2029).

Asia - Pacific Human Insulin Market

The Asia - Pacific Human Insulin Market size is estimated at USD 7.29 billion in 2023, and is expected to reach USD 8.27 billion by 2028, growing at a CAGR of 2.54% during the forecast period (2023-2028).

Asia-Pacific Glucagon-like Peptide-1 (GLP-1) Agonists Market

The Asia-Pacific Glucagon-like Peptide-1 Agonists Market size is estimated at USD 0.9 billion in 2024, and is expected to reach USD 1.17 billion by 2029, growing at a CAGR of 5.38% during the forecast period (2024-2029).

Europe Glucagon-Like Peptide-1 (GLP-1) Agonists Market

The Europe Glucagon-Like Peptide-1 Agonists Market size is estimated at USD 3.94 billion in 2024, and is expected to reach USD 5.25 billion by 2029, growing at a CAGR of 5.90% during the forecast period (2024-2029).

North America Glucagon-like Peptide-1 Agonists Market

The North America Glucagon-like Peptide-1 Agonists Market size is estimated at USD 6.94 billion in 2024, and is expected to decline to USD 6.68 billion by 2029.

Glucagon-like Peptide-1 (GLP-1) Agonists Market

The Glucagon-like Peptide-1 Agonists Market size is estimated at USD 11.99 billion in 2024, and is expected to reach USD 12.63 billion by 2029, growing at a CAGR of 1.12% during the forecast period (2024-2029).

Asia-Pacific Diabetes Care Drugs Market

The Asia-Pacific Diabetes Care Drugs Market size is estimated at USD 24.99 billion in 2024, and is expected to reach USD 28.70 billion by 2029, growing at a CAGR of 2.81% during the forecast period (2024-2029).

Latin America Diabetes Care Drugs Market

The Latin America Diabetes Care Drugs Market size is estimated at USD 4.71 billion in 2024, and is expected to reach USD 5.58 billion by 2029, growing at a CAGR of 3.48% during the forecast period (2024-2029).

MEA Insulin Pens Market

The MEA Insulin Pens Market size is estimated at USD 1.02 billion in 2024, and is expected to reach USD 1.13 billion by 2029, growing at a CAGR of 2.19% during the forecast period (2024-2029).

Europe Insulin Pens Market

The Europe Insulin Pens Market size is estimated at USD 2.13 billion in 2023 and is expected to reach USD 2.29 billion by 2028, growing at a CAGR of 1.45% during the forecast period (2023-2028).

Mergers And Acquisitions In The Diabetes Market

The Mergers And Acquisitions In The Diabetes Market size is estimated at USD 85.73 billion in 2024, and is expected to reach USD 102.76 billion by 2029, growing at a CAGR of 3.69% during the forecast period (2024-2029).

Canada Diabetes Care Drugs And Devices Market

The Canada Diabetes Care Drugs And Devices Market size is estimated at USD 5.40 billion in 2024, and is expected to reach USD 7.04 billion by 2029, growing at a CAGR of 4.75% during the forecast period (2024-2029).

Global Rare Hemophilia Factors Market

The rare hemophilia factors market is expected to record a CAGR of 4.3% over the forecast period (2022-2027).

Menopausal Hot Flashes Market

The menopausal hot flashes market is projected to register a CAGR of 3.4% during the forecast period.

Europe Insulin Drugs And Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market

The Europe Insulin Drugs And Glucagon-Like Peptide 1 Receptor Agonist Market size is estimated at USD 9.62 billion in 2024, and is expected to reach USD 12.05 billion by 2029, growing at a CAGR of 4.61% during the forecast period (2024-2029).

Egypt Diabetes Care Devices Market

The Egypt Diabetes Care Devices Market size is estimated at USD 396 million in 2024, and is expected to reach USD 559 million by 2029, growing at a CAGR of 3.36% during the forecast period (2024-2029).

Egypt Diabetes Drugs Market

The Egypt Diabetes Drugs Market size is estimated at USD 414.66 million in 2024, and is expected to reach USD 480.70 million by 2029, growing at a CAGR of 3% during the forecast period (2024-2029).

Saudi Arabia Diabetes Drugs Market

The Saudi Arabia Diabetes Drugs Market size is estimated at USD 1.87 billion in 2024, and is expected to reach USD 2.89 billion by 2029, growing at a CAGR of 9% during the forecast period (2024-2029).

Thailand Diabetes Care Devices Market

The Thailand Diabetes Care Devices Market size is estimated at USD 128.94 million in 2024, and is expected to reach USD 175.49 million by 2029, growing at a CAGR of 6.36% during the forecast period (2024-2029).

Philippines Diabetes Care Devices Market

The Philippines Diabetes Care Devices Market size is expected to grow from USD 80.82 million in the current year to USD 101.68 million by the forecast period, at a CAGR of 4.70% during the forecast period.

Mexico Diabetes Drugs Market

The Mexico Diabetes Drugs Market size is estimated at USD 2.04 billion in 2024, and is expected to reach USD 2.39 billion by 2029, growing at a CAGR of 3.30% during the forecast period (2024-2029).

Vietnam Diabetes Care Drugs Market

The Vietnam Diabetes Care Drugs Market size is estimated at USD 208.45 million in 2024, and is expected to reach USD 249.97 million by 2029, growing at a CAGR of 3.70% during the forecast period (2024-2029).

India Diabetes Care Drugs Market

The India Diabetes Care Drugs Market size is estimated at USD 1.7 billion in 2024, and is expected to reach USD 2.01 billion by 2029, growing at a CAGR of 3.5% during the forecast period (2024-2029).

Russia Diabetes Drugs Market

The Russia Diabetes Drugs Market size is estimated at USD 1.04 billion in 2024, and is expected to reach USD 1.31 billion by 2029, growing at a CAGR of 4.5% during the forecast period (2024-2029).

South Korea Diabetes Care Devices Market

The South Korea Diabetes Care Devices Market size is estimated at USD 457.06 million in 2024, and is expected to reach USD 529.86 million by 2029, growing at a CAGR of 3% during the forecast period (2024-2029).

Human Recombinant Insulin Market

The Human Recombinant Insulin Market size is estimated at USD 28.47 billion in 2024, and is expected to reach USD 32.20 billion by 2029, growing at a CAGR of greater than 2.9% during the forecast period (2024-2029).

Combination Anti-Diabetes Drugs Market

The Combination Anti-Diabetes Drugs Market size is estimated at USD 1.09 billion in 2024, and is expected to reach USD 1.85 billion by 2029, growing at a CAGR of 10.87% during the forecast period (2024-2029).

North America Insulin Delivery Devices Market

The North America Insulin Delivery Devices Market size is estimated at USD 14.59 million in 2024, and is expected to reach USD 18.91 million by 2029, growing at a CAGR of 5.06% during the forecast period (2024-2029).

North America Insulin Pens Market

The North America Insulin Pens Market size is estimated at USD 11.99 billion in 2024, and is expected to reach USD 14.87 billion by 2029, growing at a CAGR of 4.87% during the forecast period (2024-2029).

Australia And New Zealand Diabetes Devices Market

The Australia And New Zealand Diabetes Devices Market size is estimated at USD 1.14 billion in 2024, and is expected to reach USD 1.30 billion by 2029, growing at a CAGR of 2.70% during the forecast period (2024-2029).

Blood Disorder Therapeutics Market

The Blood Disorder Therapeutics Market is expected to register a CAGR of 6.2% during the forecast period.

Short-acting Insulin Market

The Short-acting Insulin Market size is estimated at USD 7.23 billion in 2024, and is expected to reach USD 8.58 billion by 2029, growing at a CAGR of 3.46% during the forecast period (2024-2029).

Insulin Glargine Market

The Insulin Glargine Market size is estimated at USD 1.54 billion in 2024, and is expected to reach USD 2.09 billion by 2029, growing at a CAGR of 6.28% during the forecast period (2024-2029).

Middle East and Africa Diabetes Care Devices Market

The Middle East and Africa Diabetes Care Devices Market size is estimated at USD 2.43 billion in 2024, and is expected to reach USD 2.97 billion by 2029, growing at a CAGR of 4.12% during the forecast period (2024-2029).

Oman Diabetes Drugs Market

The Oman Diabetes Drugs Market size is estimated at USD 212.26 million in 2024, and is expected to reach USD 292.31 million by 2029, growing at a CAGR of 6.61% during the forecast period (2024-2029).

South Africa Diabetes Drugs Market

The South Africa Diabetes Drugs Market size is estimated at USD 340.72 million in 2024, and is expected to reach USD 384.74 million by 2029, growing at a CAGR of 2.46% during the forecast period (2024-2029).

Malaysia Diabetes Care Devices Market

The Malaysia Diabetes Care Devices Market size is estimated at USD 307.27 million in 2023, and is expected to reach USD 386.59 million by 2028, growing at a CAGR of 4.70% during the forecast period (2023-2028).

Indonesia Diabetes Care Drugs Market

The Indonesia Diabetes Care Drugs Market size is estimated at USD 301.55 million in 2024, and is expected to reach USD 370.43 million by 2029, growing at a CAGR of 4.20% during the forecast period (2024-2029).

Malaysia Diabetes Care Drugs Market

The Malaysia Diabetes Care Drugs Market size is estimated at USD 389.13 million in 2024, and is expected to reach USD 423.21 million by 2029, growing at a CAGR of 3.10% during the forecast period (2024-2029).

China Diabetes Care Drugs Market

The China Diabetes Care Drugs Market size is estimated at USD 12.34 billion in 2024, and is expected to reach USD 14.10 billion by 2029, growing at a CAGR of 2.70% during the forecast period (2024-2029).

Asia-Pacific Insulin Delivery Devices Market

The Asia-Pacific Insulin Delivery Devices Market size is estimated at USD 18.88 billion in 2024, and is expected to reach USD 21.55 billion by 2029, growing at a CAGR of greater than 2.68% during the forecast period (2024-2029).

Middle East and Africa Insulin Delivery Devices Market

The Middle East and Africa Insulin Delivery Devices Market size is estimated at USD 1.96 billion in 2024, and is expected to reach USD 2.27 billion by 2029, growing at a CAGR of 2.99% during the forecast period (2024-2029).

Anorexiants Market

The anorexiants market studied is anticipated to register a CAGR of 3.9% during the forecast period.

Incretin-based Drugs Market

The incretin-based drugs market is expected to register a CAGR of 5.2% during the forecast period.

Endocrinology Drugs Market

The endocrinology drugs market is expected to register a CAGR of 6.8% over the forecast period.

Germany Diabetes Drugs Market

The Germany Diabetes Drugs Market size is estimated at USD 4.06 billion in 2024, and is expected to reach USD 4.81 billion by 2029, growing at a CAGR of 3.47% during the forecast period (2024-2029).

Italy Diabetes Drugs Market

The Italy Diabetes Drugs Market size is estimated at USD 1.12 billion in 2024, and is expected to reach USD 1.31 billion by 2029, growing at a CAGR of 3% during the forecast period (2024-2029).

United Kingdom (UK) Diabetes Drugs Market

The United Kingdom Diabetes Drugs Market size is estimated at USD 1.06 billion in 2024, and is expected to reach USD 1.24 billion by 2029, growing at a CAGR of 3.05% during the forecast period (2024-2029).

France Diabetes Drugs Market

The France Diabetes Drugs Market size is estimated at USD 1.42 billion in 2024, and is expected to reach USD 1.67 billion by 2029, growing at a CAGR of 3.22% during the forecast period (2024-2029).

Spain Diabetes Care Drugs Market

The Spain Diabetes Care Drugs Market size is estimated at USD 1.21 billion in 2024, and is expected to reach USD 1.52 billion by 2029, growing at a CAGR of 4.5% during the forecast period (2024-2029).

Brazil Diabetes Drugs Market

The Brazil Diabetes Drugs Market size is estimated at USD 1.66 billion in 2024, and is expected to reach USD 2.02 billion by 2029, growing at a CAGR of 4.10% during the forecast period (2024-2029).

Australia Diabetes Care Drugs Market

The Australia Diabetes Care Drugs Market size is estimated at USD 815.19 million in 2024, and is expected to reach USD 972.88 million by 2029, growing at a CAGR of 3.60% during the forecast period (2024-2029).

Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Market

The Latin America Glucagon-like Peptide-1 Agonists Market size is estimated at USD 203.89 million in 2024, and is expected to reach USD 266.48 million by 2029, growing at a CAGR of 5.5% during the forecast period (2024-2029).

Latin America Human Insulin Drugs Market

The Latin America Human Insulin Drugs Market size is estimated at USD 1.51 billion in 2024, and is expected to reach USD 1.75 billion by 2029, growing at a CAGR of 3.10% during the forecast period (2024-2029).

Latin America Meglitinide Market

The Latin America Meglitinide Market size is estimated at USD 0.22 billion in current year, and is expected to reach USD 0.26 million by forecast year, growing at a CAGR of 3.30% during the forecast period.

Europe Meglitinide Market

The Europe Meglitinide Market size is estimated at USD 1.08 billion in current year, and is expected to reach USD 1.21 billion by forecast year, growing at a CAGR of 2.30% during the forecast period.

North America Meglitinide Market

The North America Meglitinide Market size is expected to grow from USD 0.98 billion in current year to USD 1.05 billion by forecat year, at a CAGR of 1.50% during the forecast period.

APAC Meglitinide Market

The Asia-Pacific Meglitinide Market size is estimated at USD 1.62 billion in current year, and is expected to reach USD 1.76 billion by forecat year, growing at a CAGR of 1.70% during the forecast period.

Middle East And Africa Meglitinide Market

The Middle-East and Africa Meglitinide Market size is estimated at USD 0.2 billion in current year, and is expected to reach USD 0.3 billion by forecast year, growing at a CAGR of 4% during the forecast period.

Germany Insulin Drugs And Delivery Devices Market

The Germany Insulin Drugs And Delivery Devices Market size is estimated at USD 1.10 billion in 2024, and is expected to reach USD 1.13 billion by 2029, growing at a CAGR of 0.5% during the forecast period (2024-2029).

Spain Insulin Drugs And Delivery Devices Market

The Spain Insulin Drugs and Delivery Devices Market size is estimated at USD 0.35 billion in current year, and is expected to reach USD 0.38 million by forecast year, growing at a CAGR of 1.80% during the forecast period.

Italy Insulin Drugs and Delivery Devices Market

The Italy Insulin Drugs and Delivery Devices Market size is estimated at USD 531.86 million in 2024, and is expected to reach USD 572.96 million by 2029, growing at a CAGR of 1.5% during the forecast period (2024-2029).

Russia Insulin Drugs and Delivery Devices Market

The Russia Insulin Drugs and Delivery Devices Market size is estimated at USD 1.10 billion in 2024, and is expected to reach USD 1.14 billion by 2029, growing at a CAGR of 0.58% during the forecast period (2024-2029).

Mexico Insulin Drugs And Delivery Devices Market

The Mexico Insulin Drugs And Delivery Devices Market size is estimated at USD 546.96 million in 2024, and is expected to reach USD 572.01 million by 2029, growing at a CAGR of 0.9% during the forecast period (2024-2029).

Brazil Insulin Drugs & Delivery Devices Market

The Brazil Insulin Drugs & Delivery Devices Market size is estimated at USD 937.42 million in 2024, and is expected to reach USD 990.12 million by 2029, growing at a CAGR of 1.10% during the forecast period (2024-2029).

Latin America Insulin Delivery Devices Market

The Latin America Insulin Delivery Devices Market size is estimated at USD 7.14 million in 2024, and is expected to reach USD 8.16 million by 2029, growing at a CAGR of greater than 2% during the forecast period (2024-2029).

Novo Nordisk Reports - Industry Research

Reports Featuring Novo Nordisk